Tuesday, August 5, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Scientists unravel how the BCG vaccine leads to the destruction of bladder cancer cells

August 8, 2024
in Cancer
Reading Time: 5 mins read
0
Image 1
68
SHARES
615
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT
ADVERTISEMENT

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells. Their results, which are published today (August 1, 2024) in the journal Disease Models and Mechanisms, show that macrophages – the first line of immune cells activated after an infection – literally induce the cancer cells to commit suicide and then rapidly eat away the dead cancer cells.

Image 1

Credit: Mayra Martinez-López

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells. Their results, which are published today (August 1, 2024) in the journal Disease Models and Mechanisms, show that macrophages – the first line of immune cells activated after an infection – literally induce the cancer cells to commit suicide and then rapidly eat away the dead cancer cells.

The idea behind zebrafish Avatars (zAvatars), which are still an experimental, but very promising model, is fairly straightforward: take tumour cells from a cancer patient and inject them into zebrafish embryos. The tumours will then grow inside the embryos, effectively turning them into Avatars of that specific cancer patient. The various treatment options available for that patient can then be tested on the zAvatars – and, in a matter of days rather than several weeks, or even months, that it takes using the traditional testing in mice, it will be possible to determine the best treatment for that patient. The test has been developed and studied with samples from colorectal cancer patient samples (https://fchampalimaud.org/news/clinical-study-shows-zavatar-test-has-high-predictive-power-personalising-colorectal-cancer).

Fior had a new idea for applying the model. “When I joined Rita’s lab, as a PhD student” (in 2019), Martínez-López recalls, “we were discussing several projects I could undertake, and Rita mentioned that the BCG vaccine was being used in bladder cancer patients.” Martínez-López remembered getting the BCG against tuberculosis when she was a child in South America, and had later worked on the disease. “But it was the first time I heard of the TB vaccine as a cancer treatment”, she points out. And this immediately caught her attention. 

The (hi)story of an idea

The BCG vaccine was first used against TB in the 1920’s and then started to be used as the first cancer immunotherapy around 1976. But decades before that, in the 1890’s, William Coley, a surgeon working at the New York Hospital (now Weill Cornell Medical Center) had already tested a mix of different bacteria, coined “Coley’s toxins”, as a cancer immunotherapy!

Coley had noticed that several virtually hopeless cancer patients at the hospital went into seemingly “miraculous” remissions from their cancer when they caught a bacterial infection following the surgery performed to remove their tumours (sterile conditions for surgical procedures were then less than optimal). And his idea was that such recoveries, far from being miraculous, were in fact caused by an immune response of the patients to the infection.

Coley started trying to induce bacterial infections in a number of sarcoma patients and was able to reproduce a few cancer remissions. At the time, though, his method was far from being proven and safe – and meanwhile, other treatment methods were developed, such as radiotherapy – so his research was not pursued. But in recent years, the field of immunotherapy has gained enormous momentum, bringing new and more scientifically robust ways of boosting the immune system to fight cancer (https://fchampalimaud.org/news/check-up-19-cancer-immunotherapy).

“BCG immunotherapy is still rather empirically used” says Martínez-López. “However, since it works for many people, it has become a gold standard treatment. Surprisingly, it is a very effective immunotherapy, even when compared to so many fancy immunotherapies that are being developed.”

The treatment consists of instilling the BCG vaccine directly into the bladder. When the treatment works, the 15-year survival rate for patients with so-called “non-muscle-invasive” (early-stage) bladder cancer is 60% to 70%. However, in 30% to 50% of the cases, bladder tumours are unresponsive to BCG treatment. In these cases, the whole bladder has to be removed.

The macrophages have it

Until now, the way the BCG vaccine works as an immunomodulator to clear bladder tumours was not fully known.

The team’s idea was that immune cells, and in particular macrophages resident in the bladder, were involved. And they were able to determine what happens right after BCG is injected into zebrafish Avatars. To do this, they used so-called light sheet microscopy and confocal imaging, which allowed them to see the macrophages interacting with the tumour cells, at single cell resolution and in real time. 

The colourful movies they obtained of the process triggered by the vaccine (in which the macrophages and cancer cells were labelled with different fluorescent dyes) showed that macrophages are heavily recruited to the tumour site upon BCG injection, directly killing human bladder cancer cells via a process of cell suicide (apoptosis) dependent on a substance called tumor necrosis factor (TNF) secreted by macrophages, that acts as a potent signal molecule of the immune system. 

They further showed that, when macrophages were depleted in the zAvatar, the anti-tumour effects of the BCG vaccine were completely blocked, thus demonstrating that macrophages are indeed crucial for the initial anti-tumour response.

“What Mayra saw”, says Rita Fior, “was that if you inject BCG, you have a marked increase of the amount of macrophages going into the tumour.” And in the presence of BCG, the immune cells changed color from red to yellow, which meant they expressed TNF.

“Not only did we unravel the mechanisms involved in the first steps of the vaccine’s anti-tumoural action, we also demonstrated that the zebrafish Avatar model is a powerful preclinical tool for drug discovery in oncology”, concludes Martínez-López.



Journal

Disease Models & Mechanisms

DOI

10.1242/dmm.050693

Method of Research

Experimental study

Subject of Research

Animals

Article Title

Macrophages directly kill bladder cancer cells through TNF signaling in an early response to BCG therapy

Article Publication Date

8-Aug-2024

Share27Tweet17
Previous Post

‘Fuel to the fire’: repeated climate-sceptic claims enough to nudge even the strongest of climate change endorsers

Next Post

Cleveland Clinic study adds to increasing evidence that sugar substitute erythritol raises cardiovascular risk

Related Posts

blank
Cancer

AI Predicts Gastric Cancer Outcomes via CEA

August 5, 2025
blank
Cancer

Nanoparticles Transforming CAR-T Therapy: Production to Performance

August 5, 2025
blank
Cancer

Emerging Study Explores Rising Colorectal Cancer Rates and Screening Trends in Younger US Adults

August 5, 2025
blank
Cancer

Immune Landscape in Colorectal Cancer KRAS Variants

August 5, 2025
blank
Cancer

ROCK Inhibition Halts Glioblastoma by Targeting PI3K/AKT

August 5, 2025
blank
Cancer

UCLA Study Finds Mailing At-Home Test Kits Boosts Colorectal Cancer Screening Among Ages 45–49

August 4, 2025
Next Post
Stanley Hazen, MD, PhD, Cleveland Clinic

Cleveland Clinic study adds to increasing evidence that sugar substitute erythritol raises cardiovascular risk

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27529 shares
    Share 11008 Tweet 6880
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    939 shares
    Share 376 Tweet 235
  • Bee body mass, pathogens and local climate influence heat tolerance

    640 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    506 shares
    Share 202 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • How Aussie Skinks Outsmart Deadly Snake Venom
  • Anti-AMPAR Encephalitis Manifests as Catatonia
  • AI Predicts Gastric Cancer Outcomes via CEA
  • Uncertainty-Aware Breakthrough in Fourier Ptychography

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,184 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading